Review



antibodies against pe foxo1  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc antibodies against pe foxo1
    ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, <t>FOXO1,</t> and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.
    Antibodies Against Pe Foxo1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 45 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo1+pe/FoxO1+Rabbit+mAb/pmc11328899-313-7-11
    Average 93 stars, based on 45 article reviews
    antibodies against pe foxo1 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit"

    Article Title: Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit

    Journal: Science Advances

    doi: 10.1126/sciadv.ado1533

    ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, FOXO1, and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.
    Figure Legend Snippet: ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, FOXO1, and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.

    Techniques Used: Expressing, Immunohistochemistry, Real-time Polymerase Chain Reaction, Western Blot, In Vitro, Isolation, Transduction, Injection, Activity Assay, Fluorescence, Staining

    ( A to E ) Effect of EPI on FOXO1 protein expression in WT and USP22-null MDA-MB-231 cells without [(A) and (B)] or with MG132 treatment [(C) and (D)]. The mRNA levels of FOXO1 were analyzed by real-time RT-PCR (E). ( F to I ) Analysis of USP22, FOXO1, and ATGL expression levels by IHC in syngeneic tumor tissues as shown in . Representative images (F) (scale bars, 50 μm) and quantification data [(G) to (I)] are shown. ( J to M ) FOXO1 interaction in HEK239T cells transiently transfected with FOXO1 and USP22 (J) or USP22 truncated mutants (K) expressing plasmids and in MDA-MB-231 cells (L) or further with EPI treatment (M). WB, Western blotting. WCL, whole cell lysate. ( N to P ) Analysis of FOXO1 ubiquitination in HEK293T cells coexpressed with USP22 (N) and its mutants (O) and in USP22 WT and KO MDA-MB-231 cells (P). ( Q ) Immunoblot analysis of FOXO1 protein degradation in HEK293T cells transfected with or without USP22 ( n = 3). ( R ) Analysis of FOXO1 binding to Atgl promoter by ChIP in WT and USP22 KO MDA-MB-231 cells ( n = 5). ( S ) Reconstitution of FOXO1 expression in USP22-null MDA-MB-231 cells restored ATGL expression. ( T to Y ) Analysis of FOXO1 expression in human breast cancer tissues [(T) and (U) with para-tumor tissues as controls or (V) and (W) in EPI high and EPI low groups] as well as its correlation with USP22 (X) and EPI (Y). Scale bars, 50 μm. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of three or more independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ****P < 0.0001. ns, no statistical significance.
    Figure Legend Snippet: ( A to E ) Effect of EPI on FOXO1 protein expression in WT and USP22-null MDA-MB-231 cells without [(A) and (B)] or with MG132 treatment [(C) and (D)]. The mRNA levels of FOXO1 were analyzed by real-time RT-PCR (E). ( F to I ) Analysis of USP22, FOXO1, and ATGL expression levels by IHC in syngeneic tumor tissues as shown in . Representative images (F) (scale bars, 50 μm) and quantification data [(G) to (I)] are shown. ( J to M ) FOXO1 interaction in HEK239T cells transiently transfected with FOXO1 and USP22 (J) or USP22 truncated mutants (K) expressing plasmids and in MDA-MB-231 cells (L) or further with EPI treatment (M). WB, Western blotting. WCL, whole cell lysate. ( N to P ) Analysis of FOXO1 ubiquitination in HEK293T cells coexpressed with USP22 (N) and its mutants (O) and in USP22 WT and KO MDA-MB-231 cells (P). ( Q ) Immunoblot analysis of FOXO1 protein degradation in HEK293T cells transfected with or without USP22 ( n = 3). ( R ) Analysis of FOXO1 binding to Atgl promoter by ChIP in WT and USP22 KO MDA-MB-231 cells ( n = 5). ( S ) Reconstitution of FOXO1 expression in USP22-null MDA-MB-231 cells restored ATGL expression. ( T to Y ) Analysis of FOXO1 expression in human breast cancer tissues [(T) and (U) with para-tumor tissues as controls or (V) and (W) in EPI high and EPI low groups] as well as its correlation with USP22 (X) and EPI (Y). Scale bars, 50 μm. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of three or more independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ****P < 0.0001. ns, no statistical significance.

    Techniques Used: Expressing, Quantitative RT-PCR, Transfection, Western Blot, Ubiquitin Proteomics, Binding Assay

    ( A and B ) Proteomic analysis of USP22 phosphorylation from HEK293T cells transfected with or without Flag-AKT. The spectra of peptides carrying phosphorylated peptides (A) and the identified phosphorylation residues of USP22 (top) and AKT (bottom) (B) are shown. ( C and D ) Analysis of phosphorylation (C) and ubiquitination (D) with USP22 and its phosphorylation mutant. ( E ) Analysis of FOXO1 interaction with USP22 and its phosphorylation mutant. ( F and G ) Analysis of protein stability of USP22 and its phosphorylation mutant ( n = 3). ( H to O ) Analysis of USP22 phosphorylation in human breast cancer by IHC. Representative images in tumor and para-controls (H) or in EPI high and EPI low groups (J) as well as the quantification from 65 patients [(I) and (K)] are shown. Scale bars, 50 μm. Statistical analyses of the correlation p-USP22-Thr 147 levels with EPI (L), total USP22 (M), FOXO1 (N), and ATGL (O) are shown. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by unpaired Student’s t test. Data are expressed as means ± SD of three or more independent experiments. ** P < 0.01; **** P < 0.0001; ns, no statistical significance.
    Figure Legend Snippet: ( A and B ) Proteomic analysis of USP22 phosphorylation from HEK293T cells transfected with or without Flag-AKT. The spectra of peptides carrying phosphorylated peptides (A) and the identified phosphorylation residues of USP22 (top) and AKT (bottom) (B) are shown. ( C and D ) Analysis of phosphorylation (C) and ubiquitination (D) with USP22 and its phosphorylation mutant. ( E ) Analysis of FOXO1 interaction with USP22 and its phosphorylation mutant. ( F and G ) Analysis of protein stability of USP22 and its phosphorylation mutant ( n = 3). ( H to O ) Analysis of USP22 phosphorylation in human breast cancer by IHC. Representative images in tumor and para-controls (H) or in EPI high and EPI low groups (J) as well as the quantification from 65 patients [(I) and (K)] are shown. Scale bars, 50 μm. Statistical analyses of the correlation p-USP22-Thr 147 levels with EPI (L), total USP22 (M), FOXO1 (N), and ATGL (O) are shown. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by unpaired Student’s t test. Data are expressed as means ± SD of three or more independent experiments. ** P < 0.01; **** P < 0.0001; ns, no statistical significance.

    Techniques Used: Phospho-proteomics, Transfection, Ubiquitin Proteomics, Mutagenesis

    ( A to E ) 4T1 TNBC cells were injected into the mammary fat pad of BALB/c mice ( N = 5 each group). Tumor volume (A), bioluminescence activity [(B) and (C)], and tumor weight [(D) and (E)] were measured. ( F to H ) The metastases of the lung were measured by luminol fluorescence [(B) and (H)] and H&E staining [(F) and (G)]. Lung tissue sections were analyzed by H&E staining [(F) and (G)]. Representative lung metastasis (F) and quantifications of five mice each group (G) are shown. ( I to L ) Lipid analysis of syngeneic tumors from (D) by lipid BODIPY [(I) and (J)], DAG (K), and FFAs (L). MFI, mean fluorescence intensity. ( M to O ) IHC analysis of USP22, FOXO1, and ATGL expression levels in syngeneic tumor tissue sections from (D). Quantification data of all five mice each group [(M) to (O)] are shown. (P) Model of targeting chronic stress–mediated cancer metastasis and lipolysis by USP22. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ****P < 0.0001; ns, no statistical significance.
    Figure Legend Snippet: ( A to E ) 4T1 TNBC cells were injected into the mammary fat pad of BALB/c mice ( N = 5 each group). Tumor volume (A), bioluminescence activity [(B) and (C)], and tumor weight [(D) and (E)] were measured. ( F to H ) The metastases of the lung were measured by luminol fluorescence [(B) and (H)] and H&E staining [(F) and (G)]. Lung tissue sections were analyzed by H&E staining [(F) and (G)]. Representative lung metastasis (F) and quantifications of five mice each group (G) are shown. ( I to L ) Lipid analysis of syngeneic tumors from (D) by lipid BODIPY [(I) and (J)], DAG (K), and FFAs (L). MFI, mean fluorescence intensity. ( M to O ) IHC analysis of USP22, FOXO1, and ATGL expression levels in syngeneic tumor tissue sections from (D). Quantification data of all five mice each group [(M) to (O)] are shown. (P) Model of targeting chronic stress–mediated cancer metastasis and lipolysis by USP22. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ****P < 0.0001; ns, no statistical significance.

    Techniques Used: Injection, Activity Assay, Fluorescence, Staining, Expressing

    Related Articles

    other:

    Article Title: Dysregulated PI3K Signaling in B Cells of CVID Patients
    Article Snippet: Cell cultivation and activation: Survival of B-cell subpopulations was determined after cultivation of 10.000 sorted CD21 low and CD21 pos B cells in RPMI 10% FCS for 48 h. Proliferative marker Ki67 was determined after stimulation of 0.5 × 10 6 PBMCs with CpG (cat. # tlrl-2006-1, Invivogen, San Diego, CA, USA) and anti-IgM (cat. #202201, SouthernBiotech, Birmingham, AL, USA) or IL-4 (cat. #11340043, Immunotools, Friesoythe, Germany), anti-CD40 (cat. #MAB6321, R&D Systems, Minneapolic, MN, USA) and anti-IgM for 48 h. Induction of HIF1α and GLUT1 was determined after stimulation of PBMCs with anti-IgM (cat. #202214, Southern Biotech, Birmingham, AL, USA) for 40 h. Antibodies and dyes used in this study: CD3 PE-Cy7 (UCHT1 cat. #300420), CD4 BV421 (RPA-T4 cat. #300532), CD10 BV605 (HI10a cat. #312222), CD19 BV421 (HIB19) (cat. #302234), CD19 APC-Cy7 (HIB19 cat. #302218), CD21 PE-Cy7 (Bu32 cat. #354912), CD27 BV421 (M-T271 cat. #356418), CD38 PerCp-Cy5.5 (HIT2 cat. #303522), CD38 APC (HIT2 cat. #303510), IgD BV785 (IA6-2 cat. #348242), IgM APC-Cy7 (MHM-88 cat. #314520), IgM BV421 (MHM-88 cat. #314516), Lambda FITC (MHL-38 cat. #316606), HIF1α PE (546-16 cat. #359703), KI67 AF488 (ki67 cat. #350507), Zombie UV (cat. #423107) (all BioLegend, San Diego, CA); IgD FITC (cat. #203202), IgD PE (cat. #203209), IgA PE (cat. #205009) (all Southern Biotech, Birmingham, AL); IgM AF647 (cat. #109606129), IgM AF488 (cat. #109545129 (both Jackson ImmunoResearch, West Grove, PA, USA), CD21 PE (BL13) (cat. #A32536), (both Beckman Coulter, Brea, CA); Glut1 AF647 (EPR3915) (cat. #ab195020), Mitotracker Red CMXRos (cat. #ab176832) (both Abcam, Cambridge, UK); CD27 BV605 (L128 cat. #562655), S6(pS235/pS236) AF647 (N7-548 cat. #560435), IgG AF700 (G18-145 cat. #G18145), Annexin V PE (cat. #5165875X) (all BD Biosciences, La Jolla, CA, USA); mTOR(pS2448) PE (MRRBY cat. #12971842) (ebioscience, San Diego, CA, USA); AKT (pS473) AF488 (D9E cat. #4071S), FOXO1 PE (C29H4 cat. #14262), goat anti-rabbit AF647 (cat. #4414) (Cell Signaling Technologies, Frankfurt, Germany); GLUT1 rabbit (cat. #NB300666) (Novus Biologicals, Centennial, CO, USA); 2-NBDG (cat. #N13195) (Invitrogen, Carlsbad, CA, USA); CD19(pY531) rabbit (cat. #ab63443) (Abcam, Cambridge, UK).

    Control:

    Article Title: Metabolic reprogramming of human CD8 + memory T cells through loss of SIRT1
    Article Snippet: After surface marker staining, cells were permeabilized and fixed using the Foxp3/Transcription Factor Fixation/Permeabilization Concentrate and Diluent kit (eBioscience). .. Intracellular GZMB-FITC (515403; BioLegend), FoxO1-PE (14262; Cell Signaling Technology), and isotope control (5742; Cell Signaling Technology) staining was performed in FOXP3 perm/wash buffer for 1 h at 4°C. ..

    Staining:

    Article Title: Metabolic reprogramming of human CD8 + memory T cells through loss of SIRT1
    Article Snippet: After surface marker staining, cells were permeabilized and fixed using the Foxp3/Transcription Factor Fixation/Permeabilization Concentrate and Diluent kit (eBioscience). .. Intracellular GZMB-FITC (515403; BioLegend), FoxO1-PE (14262; Cell Signaling Technology), and isotope control (5742; Cell Signaling Technology) staining was performed in FOXP3 perm/wash buffer for 1 h at 4°C. ..



    Similar Products

    93
    Cell Signaling Technology Inc antibodies against pe foxo1
    ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, <t>FOXO1,</t> and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.
    Antibodies Against Pe Foxo1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo1+pe/FoxO1+Rabbit+mAb/pmc11328899-313-7-11
    Average 93 stars, based on 1 article reviews
    antibodies against pe foxo1 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anti mouse foxo1 pe cell signaling
    ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, <t>FOXO1,</t> and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.
    Anti Mouse Foxo1 Pe Cell Signaling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo1+pe/FoxO1+Rabbit+mAb/pmc10897180__41467_2024_45984_MOESM3_ESM-46-30-33
    Average 93 stars, based on 1 article reviews
    anti mouse foxo1 pe cell signaling - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc foxo1 pe
    ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, <t>FOXO1,</t> and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.
    Foxo1 Pe, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo1+pe/FoxO1+Rabbit+mAb/pm37696797-209-125-134
    Average 93 stars, based on 1 article reviews
    foxo1 pe - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc foxo1 pe c29h4
    ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, <t>FOXO1,</t> and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.
    Foxo1 Pe C29h4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo1+pe/FoxO1+Rabbit+mAb/pmc10311431-151-0-4
    Average 93 stars, based on 1 article reviews
    foxo1 pe c29h4 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Becton Dickinson foxo1 pe antibody
    ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, <t>FOXO1,</t> and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.
    Foxo1 Pe Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo1+pe/pcmv5+flag+foxo1+vectors/10__1158_slash_2326___6066__cir___22___0705-116-24-11
    Average 90 stars, based on 1 article reviews
    foxo1 pe antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anti foxo1 pe
    Analysis of critical transcription factors in wild-type (WT) and Mb1-cre ABCB7 cKO Fr. C cells (B220 + CD19 + CD43 + BP-1 + ). ( A–G ) Intracellular flow cytometry analysis of EBF1 ( A ), E47 (E2A) ( B ), <t>FOXO1</t> ( C ), PAX5 ( D ), IKAROS ( E ), AIOLOS ( F ), and IRF4 ( G ) expression. Quantification of MdFI is shown on the right of each plot. Isotype controls are shown in gray. Offset histograms are representative of at least three independent experiments (total of 6–10 mice/group). ( H, I ) Flow cytometry analysis of CD2 ( H ) and CD25 ( I ) expression. Indicated values are the proportion of Fr. C cells positive for either marker, and quantifications are shown on the right of each plot. Offset histograms are representative of three independent experiments (total of five mice/group). ( J ) Intracellular flow cytometry analysis of TdT expression in Fr. B and Fr. C cells. Indicated values are the proportion of cells positive for TdT expression, and quantifications are shown on the right. Offset histograms are representative of three independent experiments (total of 5–7 mice/group). ( K ) Quantitative real-time PCR analysis of Rag1 and Rag2 expression in sorted Fr. B and Fr. C cells. 18S rRNA was used as an endogenous control, and relative expression values were normalized to expression in WT Fr. B cells. Results were obtained from three independent experiments (total of 3–4 mice/group). ( A–K ) Error bars represent SEM, and p-values are indicated above the data. Statistics were obtained by using an unpaired Student’s t -test.
    Anti Foxo1 Pe, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/foxo1+pe/FoxO1+Rabbit+mAb/pmc08585479-39-2-8
    Average 93 stars, based on 1 article reviews
    anti foxo1 pe - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, FOXO1, and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.

    Journal: Science Advances

    Article Title: Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit

    doi: 10.1126/sciadv.ado1533

    Figure Lengend Snippet: ( A to F ) ATGL expression in breast cancer tissues by IHC staining. Representative images from para-tumor normal tissue and cancer sections (A) and quantification from 65 patients (B) are shown. Scale bars, 50 μm. The data were further analyzed by EPI levels [(C) and (D)]. The correlation of ATGL with EPI (E) and USP22 (F) was analyzed. ( G to J ) The mRNA [(G) and (H)] and protein [(I) and (J)] levels of ATGL in MDA-MB-231 cells treated with EPI (10 nM) were determined by real-time PCR and Western blotting, respectively. ( K to M ) Intracellular lipid analysis, including BODIPY [(K) and (L)], DAG (M), and FFAs (N) in WT and USP22-null MDA-MB-231 cells treated with EPI in vitro. ( O to R ) Intracellular lipid analysis in WT and USP22-null MDA-MB-231 cells isolated from the xenograft tumors as shown in . ( S ) The protein levels of USP22, FOXO1, and ATGL in the WT 4T1 cells, USP22 KO 4T1 cells, and the USP22 KO 4T1 cells transduced with ATGL were measured. ( T to Za ) A total of 1 × 10 5 WT, USP22 KO 4T1 cells, or USP22 KO 4T1 cells transduced with ATGL were injected into the mammary fat pad of BALB/c mice. Tumor volume (T), bioluminescence activity [(U) and (V)], and tumor weight [(W) and (X)] were measured. Lung metastases were measured by luminol fluorescence [(U) and (Y)] and H&E staining of their lung sections [(Z) and (Za)]. N = 5 each group. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no statistical significance.

    Article Snippet: The cells were then stained with specific antibodies against PE-FoxO1 (14262, Cell Signaling Technology) for 1 hour at 4°C.

    Techniques: Expressing, Immunohistochemistry, Real-time Polymerase Chain Reaction, Western Blot, In Vitro, Isolation, Transduction, Injection, Activity Assay, Fluorescence, Staining

    ( A to E ) Effect of EPI on FOXO1 protein expression in WT and USP22-null MDA-MB-231 cells without [(A) and (B)] or with MG132 treatment [(C) and (D)]. The mRNA levels of FOXO1 were analyzed by real-time RT-PCR (E). ( F to I ) Analysis of USP22, FOXO1, and ATGL expression levels by IHC in syngeneic tumor tissues as shown in . Representative images (F) (scale bars, 50 μm) and quantification data [(G) to (I)] are shown. ( J to M ) FOXO1 interaction in HEK239T cells transiently transfected with FOXO1 and USP22 (J) or USP22 truncated mutants (K) expressing plasmids and in MDA-MB-231 cells (L) or further with EPI treatment (M). WB, Western blotting. WCL, whole cell lysate. ( N to P ) Analysis of FOXO1 ubiquitination in HEK293T cells coexpressed with USP22 (N) and its mutants (O) and in USP22 WT and KO MDA-MB-231 cells (P). ( Q ) Immunoblot analysis of FOXO1 protein degradation in HEK293T cells transfected with or without USP22 ( n = 3). ( R ) Analysis of FOXO1 binding to Atgl promoter by ChIP in WT and USP22 KO MDA-MB-231 cells ( n = 5). ( S ) Reconstitution of FOXO1 expression in USP22-null MDA-MB-231 cells restored ATGL expression. ( T to Y ) Analysis of FOXO1 expression in human breast cancer tissues [(T) and (U) with para-tumor tissues as controls or (V) and (W) in EPI high and EPI low groups] as well as its correlation with USP22 (X) and EPI (Y). Scale bars, 50 μm. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of three or more independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ****P < 0.0001. ns, no statistical significance.

    Journal: Science Advances

    Article Title: Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit

    doi: 10.1126/sciadv.ado1533

    Figure Lengend Snippet: ( A to E ) Effect of EPI on FOXO1 protein expression in WT and USP22-null MDA-MB-231 cells without [(A) and (B)] or with MG132 treatment [(C) and (D)]. The mRNA levels of FOXO1 were analyzed by real-time RT-PCR (E). ( F to I ) Analysis of USP22, FOXO1, and ATGL expression levels by IHC in syngeneic tumor tissues as shown in . Representative images (F) (scale bars, 50 μm) and quantification data [(G) to (I)] are shown. ( J to M ) FOXO1 interaction in HEK239T cells transiently transfected with FOXO1 and USP22 (J) or USP22 truncated mutants (K) expressing plasmids and in MDA-MB-231 cells (L) or further with EPI treatment (M). WB, Western blotting. WCL, whole cell lysate. ( N to P ) Analysis of FOXO1 ubiquitination in HEK293T cells coexpressed with USP22 (N) and its mutants (O) and in USP22 WT and KO MDA-MB-231 cells (P). ( Q ) Immunoblot analysis of FOXO1 protein degradation in HEK293T cells transfected with or without USP22 ( n = 3). ( R ) Analysis of FOXO1 binding to Atgl promoter by ChIP in WT and USP22 KO MDA-MB-231 cells ( n = 5). ( S ) Reconstitution of FOXO1 expression in USP22-null MDA-MB-231 cells restored ATGL expression. ( T to Y ) Analysis of FOXO1 expression in human breast cancer tissues [(T) and (U) with para-tumor tissues as controls or (V) and (W) in EPI high and EPI low groups] as well as its correlation with USP22 (X) and EPI (Y). Scale bars, 50 μm. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of three or more independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ****P < 0.0001. ns, no statistical significance.

    Article Snippet: The cells were then stained with specific antibodies against PE-FoxO1 (14262, Cell Signaling Technology) for 1 hour at 4°C.

    Techniques: Expressing, Quantitative RT-PCR, Transfection, Western Blot, Ubiquitin Proteomics, Binding Assay

    ( A and B ) Proteomic analysis of USP22 phosphorylation from HEK293T cells transfected with or without Flag-AKT. The spectra of peptides carrying phosphorylated peptides (A) and the identified phosphorylation residues of USP22 (top) and AKT (bottom) (B) are shown. ( C and D ) Analysis of phosphorylation (C) and ubiquitination (D) with USP22 and its phosphorylation mutant. ( E ) Analysis of FOXO1 interaction with USP22 and its phosphorylation mutant. ( F and G ) Analysis of protein stability of USP22 and its phosphorylation mutant ( n = 3). ( H to O ) Analysis of USP22 phosphorylation in human breast cancer by IHC. Representative images in tumor and para-controls (H) or in EPI high and EPI low groups (J) as well as the quantification from 65 patients [(I) and (K)] are shown. Scale bars, 50 μm. Statistical analyses of the correlation p-USP22-Thr 147 levels with EPI (L), total USP22 (M), FOXO1 (N), and ATGL (O) are shown. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by unpaired Student’s t test. Data are expressed as means ± SD of three or more independent experiments. ** P < 0.01; **** P < 0.0001; ns, no statistical significance.

    Journal: Science Advances

    Article Title: Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit

    doi: 10.1126/sciadv.ado1533

    Figure Lengend Snippet: ( A and B ) Proteomic analysis of USP22 phosphorylation from HEK293T cells transfected with or without Flag-AKT. The spectra of peptides carrying phosphorylated peptides (A) and the identified phosphorylation residues of USP22 (top) and AKT (bottom) (B) are shown. ( C and D ) Analysis of phosphorylation (C) and ubiquitination (D) with USP22 and its phosphorylation mutant. ( E ) Analysis of FOXO1 interaction with USP22 and its phosphorylation mutant. ( F and G ) Analysis of protein stability of USP22 and its phosphorylation mutant ( n = 3). ( H to O ) Analysis of USP22 phosphorylation in human breast cancer by IHC. Representative images in tumor and para-controls (H) or in EPI high and EPI low groups (J) as well as the quantification from 65 patients [(I) and (K)] are shown. Scale bars, 50 μm. Statistical analyses of the correlation p-USP22-Thr 147 levels with EPI (L), total USP22 (M), FOXO1 (N), and ATGL (O) are shown. Pearson correlation coefficient was used as a measure of association. Statistical significance was determined by unpaired Student’s t test. Data are expressed as means ± SD of three or more independent experiments. ** P < 0.01; **** P < 0.0001; ns, no statistical significance.

    Article Snippet: The cells were then stained with specific antibodies against PE-FoxO1 (14262, Cell Signaling Technology) for 1 hour at 4°C.

    Techniques: Phospho-proteomics, Transfection, Ubiquitin Proteomics, Mutagenesis

    ( A to E ) 4T1 TNBC cells were injected into the mammary fat pad of BALB/c mice ( N = 5 each group). Tumor volume (A), bioluminescence activity [(B) and (C)], and tumor weight [(D) and (E)] were measured. ( F to H ) The metastases of the lung were measured by luminol fluorescence [(B) and (H)] and H&E staining [(F) and (G)]. Lung tissue sections were analyzed by H&E staining [(F) and (G)]. Representative lung metastasis (F) and quantifications of five mice each group (G) are shown. ( I to L ) Lipid analysis of syngeneic tumors from (D) by lipid BODIPY [(I) and (J)], DAG (K), and FFAs (L). MFI, mean fluorescence intensity. ( M to O ) IHC analysis of USP22, FOXO1, and ATGL expression levels in syngeneic tumor tissue sections from (D). Quantification data of all five mice each group [(M) to (O)] are shown. (P) Model of targeting chronic stress–mediated cancer metastasis and lipolysis by USP22. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ****P < 0.0001; ns, no statistical significance.

    Journal: Science Advances

    Article Title: Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit

    doi: 10.1126/sciadv.ado1533

    Figure Lengend Snippet: ( A to E ) 4T1 TNBC cells were injected into the mammary fat pad of BALB/c mice ( N = 5 each group). Tumor volume (A), bioluminescence activity [(B) and (C)], and tumor weight [(D) and (E)] were measured. ( F to H ) The metastases of the lung were measured by luminol fluorescence [(B) and (H)] and H&E staining [(F) and (G)]. Lung tissue sections were analyzed by H&E staining [(F) and (G)]. Representative lung metastasis (F) and quantifications of five mice each group (G) are shown. ( I to L ) Lipid analysis of syngeneic tumors from (D) by lipid BODIPY [(I) and (J)], DAG (K), and FFAs (L). MFI, mean fluorescence intensity. ( M to O ) IHC analysis of USP22, FOXO1, and ATGL expression levels in syngeneic tumor tissue sections from (D). Quantification data of all five mice each group [(M) to (O)] are shown. (P) Model of targeting chronic stress–mediated cancer metastasis and lipolysis by USP22. Statistical significance was determined by one-way ANOVA test or unpaired Student’s t test. Data are expressed as means ± SD of five independent experiments. * P < 0.05; ** P < 0.01; *** P < 0.001; ****P < 0.0001; ns, no statistical significance.

    Article Snippet: The cells were then stained with specific antibodies against PE-FoxO1 (14262, Cell Signaling Technology) for 1 hour at 4°C.

    Techniques: Injection, Activity Assay, Fluorescence, Staining, Expressing

    Analysis of critical transcription factors in wild-type (WT) and Mb1-cre ABCB7 cKO Fr. C cells (B220 + CD19 + CD43 + BP-1 + ). ( A–G ) Intracellular flow cytometry analysis of EBF1 ( A ), E47 (E2A) ( B ), FOXO1 ( C ), PAX5 ( D ), IKAROS ( E ), AIOLOS ( F ), and IRF4 ( G ) expression. Quantification of MdFI is shown on the right of each plot. Isotype controls are shown in gray. Offset histograms are representative of at least three independent experiments (total of 6–10 mice/group). ( H, I ) Flow cytometry analysis of CD2 ( H ) and CD25 ( I ) expression. Indicated values are the proportion of Fr. C cells positive for either marker, and quantifications are shown on the right of each plot. Offset histograms are representative of three independent experiments (total of five mice/group). ( J ) Intracellular flow cytometry analysis of TdT expression in Fr. B and Fr. C cells. Indicated values are the proportion of cells positive for TdT expression, and quantifications are shown on the right. Offset histograms are representative of three independent experiments (total of 5–7 mice/group). ( K ) Quantitative real-time PCR analysis of Rag1 and Rag2 expression in sorted Fr. B and Fr. C cells. 18S rRNA was used as an endogenous control, and relative expression values were normalized to expression in WT Fr. B cells. Results were obtained from three independent experiments (total of 3–4 mice/group). ( A–K ) Error bars represent SEM, and p-values are indicated above the data. Statistics were obtained by using an unpaired Student’s t -test.

    Journal: eLife

    Article Title: The mitochondrial iron transporter ABCB7 is required for B cell development, proliferation, and class switch recombination in mice

    doi: 10.7554/eLife.69621

    Figure Lengend Snippet: Analysis of critical transcription factors in wild-type (WT) and Mb1-cre ABCB7 cKO Fr. C cells (B220 + CD19 + CD43 + BP-1 + ). ( A–G ) Intracellular flow cytometry analysis of EBF1 ( A ), E47 (E2A) ( B ), FOXO1 ( C ), PAX5 ( D ), IKAROS ( E ), AIOLOS ( F ), and IRF4 ( G ) expression. Quantification of MdFI is shown on the right of each plot. Isotype controls are shown in gray. Offset histograms are representative of at least three independent experiments (total of 6–10 mice/group). ( H, I ) Flow cytometry analysis of CD2 ( H ) and CD25 ( I ) expression. Indicated values are the proportion of Fr. C cells positive for either marker, and quantifications are shown on the right of each plot. Offset histograms are representative of three independent experiments (total of five mice/group). ( J ) Intracellular flow cytometry analysis of TdT expression in Fr. B and Fr. C cells. Indicated values are the proportion of cells positive for TdT expression, and quantifications are shown on the right. Offset histograms are representative of three independent experiments (total of 5–7 mice/group). ( K ) Quantitative real-time PCR analysis of Rag1 and Rag2 expression in sorted Fr. B and Fr. C cells. 18S rRNA was used as an endogenous control, and relative expression values were normalized to expression in WT Fr. B cells. Results were obtained from three independent experiments (total of 3–4 mice/group). ( A–K ) Error bars represent SEM, and p-values are indicated above the data. Statistics were obtained by using an unpaired Student’s t -test.

    Article Snippet: Antibody , Anti-FOXO1 PE (Rabbit monoclonal, C29H4) , Cell Signaling Technology , Cat#:14262S; RRID: AB_2798437 , FC (1:50).

    Techniques: Flow Cytometry, Expressing, Marker, Real-time Polymerase Chain Reaction

    Journal: eLife

    Article Title: The mitochondrial iron transporter ABCB7 is required for B cell development, proliferation, and class switch recombination in mice

    doi: 10.7554/eLife.69621

    Figure Lengend Snippet:

    Article Snippet: Antibody , Anti-FOXO1 PE (Rabbit monoclonal, C29H4) , Cell Signaling Technology , Cat#:14262S; RRID: AB_2798437 , FC (1:50).

    Techniques: Transgenic Assay, Selection, Concentration Assay, Sequencing, Recombinant, Flow Cytometry, EdU Assay, DNA Purification, Isolation, Colony-forming Unit Assay, Cell Cycle Assay, Software